Compare Affirm Holdings Inc (AFRM) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Affirm Holdings Inc vs Tilray Brands Inc — how do they compare? Affirm Holdings Inc trades at $75.36 (market cap $25.69B), while Tilray Brands Inc trades at $4.68 (market cap $649.42M). The key difference: Affirm Holdings Inc is far larger — about 39.6× Tilray Brands Inc's market cap, and Affirm Holdings Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| AFRM | TLRY | |
|---|---|---|
Market Cap | $25.69B | $649.42M |
Sector | Financials | Health |
52-Week High | $92.18 | $21.00 |
52-Week Low | $42.53 | $3.88 |
Enterprise Value | $32.30B | $816.55M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AFRM trades at $75.54, up 0.39% today, with a bullish technical signal and consistent earnings beats. Revenue grew to $3.22B in 2025, turning profitable with $52M net income. The stock faces resistance near $76-$78, while analyst consensus targets $96.40, implying 28% upside. Recent news highlights strong growth prospects and institutional interest.
Outlook is positive given accelerating revenue growth, expanding margins, and dominant buy-side analyst support. Key risks include high valuation multiples (P/E 69.7) and sensitivity to interest rate changes, but robust cash flow generation and market share gains support long-term upside.
TLRY trades at $4.71, up 6.56% today, with a bullish technical signal from moving averages but mixed oscillators. Revenue grew to $821M in 2025, yet the company posted a net loss of -$2.19B, reflecting profitability challenges. Recent news highlights growth initiatives, including a partnership with Wolverhampton Wanderers and a new THC pouch launch. The stock remains volatile, with a low P/S of 0.58 and P/B of 0.4, suggesting potential undervaluation amid ongoing losses.
Outlook is cautious; TLRY's path to profitability hinges on revenue growth and cost management. Risks include persistent losses, high debt, and regulatory uncertainty. Analyst consensus is mixed, with 25% buy ratings but 65% hold, indicating skepticism. Investors should weigh growth potential against financial instability and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Affirm Holdings Inc
Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.
Read more on AFRM →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
